http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4146622-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D203-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D203-14 |
filingDate | 1977-01-12^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1979-03-27^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7231c52c4b17562d17afdc4c4d98fb94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0f9014b53c42a7f43171c879203eccc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7218d97203d6ba70fd61324801f64c5 |
publicationDate | 1979-03-27^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-4146622-A |
titleOfInvention | Aziridinyl quinone anti-transplanted tumor agents |
abstract | The use of aziridinyl quinones as antitumor agents against transplanted tumors in mice is disclosed. A compound which has been found to be particularly effective is the compound 2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone. Treatment is described in connection with several transplanted mouse tumor test systems including various forms of leukemia, for example, as well as B16 melanoma, Lewis lung carcinoma, and the ependymoblastoma brain tumor system. |
priorityDate | 1977-01-12^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 195 of 195.